AMERICAN BIOCARE, INC.
(A Development Stage Company)
Pro Forma Consolidated Financial Statements
(Unaudited)
December 31, 2010 and 2009
AMERICAN BIOCARE, INC. | |
(A Development Stage Company) | |
Pre Forma Consolidated Balance Sheets | |
(Unaudited) | |
| | December 31, 2010 | | | December 31, 2009 | |
Assets | | | | | | |
Current Assets | | | | | | |
Cash | | $ | 277,496 | | | $ | 1,732 | |
Receivables | | | 471,744 | | | | - | |
Other current assets | | | 1,084 | | | | - | |
Total Current Assets | | | 750,324 | | | | 1,732 | |
Fixed Assets | | | | | | | | |
Fixed assets (net) | | | 74,200 | | | | - | |
Total Fixed Assets | | | 74,200 | | | | - | |
Other Assets | | | | | | | | |
Deposits | | | 200 | | | | - | |
Acquisition of Subsidiaries | | | - | | | | - | |
Goodwill | | | - | | | | - | |
Total Other Assets | | | 200 | | | | - | |
Total Assets | | $ | 824,724 | | | $ | 1,732 | |
Liabilities & Stockholders' Equity | | | | | | | | |
Current Liabilities | | | | | | | | |
Accounts payable and accrued expenses | | $ | 332,034 | | | $ | 102,669 | |
Accrued interest | | | 3,198 | | | | 799 | |
Notes payable related party (net of discount of $0 and $6,813) | | | 26,646 | | | | 19,833 | |
Due to affiliate | | | 3,550 | | | | 3,550 | |
Due to officers | | | 318,083 | | | | 60,000 | |
Total Current Liabilities | | | 683,511 | | | | 186,851 | |
Other Liabilities | | | | | | | | |
Notes payable | | | - | | | | - | |
Total Liabilities | | | 683,511 | | | | 186,851 | |
Stockholders' Equity (Deficit) | | | | | | | | |
Common Stock, $0.001 par value, 146,000,000 Series A Common shares | | | | | | | | |
authorized and none issued; and 4,000,000 Series B common shares issued and | | | | | | | | |
outstanding authorized and 3,512,139 and 3,069,111 shares issued at December 31, 2010 and 2009 | | | 3,512 | | | | 3,069 | |
Preferred Stock, $0.001 par value, 5,000,000 shares authorized, none issued | | | - | | | | - | |
Additional paid in capital | | | 1,362,317 | | | | 605,787 | |
Deficit accumulated during the development stage | | | (1,224,616 | ) | | | (793,975 | ) |
Total Equity | | | 141,213 | | | | (185,119 | ) |
Total Liabilities and Stockholders' Equity | | $ | 824,724 | | | $ | 1,732 | |
AMERICAN BIOCARE, INC. |
(A Development Stage Company) |
Pre Forma Consolidated Statement of Operations |
(Unaudited) |
|
| | | | For the Period from February 28, 1997 (Inception) to December 31, 2010 |
| | December 31, 2010 | | December 31, 2009 |
Revenues | | $ | 4,410,211 | | $ | - | | $ | 4,410,211 | |
Cost of Sales | | | 3,381,480 | | | - | | | 3,381,480 | |
Gross Margin | | | 1,028,731 | | | - | | | 1,028,731 | |
General & Administrative | | | | | | | | | | |
Consulting fees-related parties | | | 974,000 | | | 456,500 | | | 1,600,902 | |
Professional fees | | | 172,142 | | | 59,965 | | | 288,058 | |
Salaries and wages | | | - | | | - | | | - | |
Rent | | | 35,092 | | | 6,600 | | | 56,792 | |
Other general and administrative | | | 650,478 | | | 11,541 | | | 682,082 | |
Total Expenses | | | 1,831,712 | | | 534,606 | | | 2,627,834 | |
Net operating loss | | | (802,981 | ) | | (534,606 | | | (1,599,103 | ) |
Other income and expenses | | | | | | | | | | |
Cancellation of accounts payable | | | 65,000 | | | - | | | 65,000 | |
Interest expense | | | (9,504 | ) | | (4,718 | | | (14,222 | ) |
Net loss | | $ | (747,485 | ) | $ | (539,324 | | $ | (1,548,325 | ) |